BioCryst Pharmaceuticals
BCRX
BCRX
230 hedge funds and large institutions have $2.07B invested in BioCryst Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 93 increasing their positions, 61 reducing their positions, and 36 closing their positions.
Holders
230
Holders Change
-4
Holders Change %
-1.71%
% of All Funds
3.71%
Holding in Top 10
5
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-16.67%
% of All Funds
0.08%
New
34
Increased
93
Reduced
61
Closed
36
Calls
$53M
Puts
$22.5M
Net Calls
+$30.6M
Net Calls Change
-$5.65M